Innegra™, a Patented Brand of High-Performance Yarns, Unveils New Product Options
20 févr. 2024 09h00 HE
|
Quantum
GREENSBORO, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Quantum Materials, LLC (“Quantum”) is set to unveil the latest innovations of Innegra™ at JEC World, the largest composite trade show globally....
Kraig Biocraft Laboratories Announces Creation of Production Ready Spider Silk Hybrid: BAM 1
06 févr. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) creates BAM 1, a new recombinant spider silk superfiber hybrid
Xeriant Signs MOU with Innovative Materials Processor for NEXBOARD™
31 janv. 2024 08h05 HE
|
Xeriant, Inc.
Xeriant (OTCQB: XERI) advances Manufacturing & Certification Process, as well as Material Sourcing for revolutionary high-demand eco-friendly products
Active Pharmaceutical Ingredients Market Size Worth USD 329.80 Billion in 2032 | Emergen Research
04 janv. 2024 07h48 HE
|
Emergen Research
Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global Active Pharmaceutical Ingredients (API) market, valued at USD 144.70 Billion in 2022, is poised to experience a rapid revenue Compound Annual...
AIAA Announces Plans for CEO Transition
03 janv. 2024 11h30 HE
|
AIAA
AIAA CEO Dan Dumbacher will step down on Sept. 30, 2024. Russell Reynolds Associates will help conduct the national search for the next AIAA CEO.
Nano Dimension Announces Preliminary All Cash Proposal to Acquire Stratasys for $16.50 per share
23 déc. 2023 09h00 HE
|
Nano Dimension Ltd.
Waltham, Mass., Dec. 23, 2023 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, or “Nano” or the “Company”), a leading supplier of Additively Manufactured Electronics...
Global Drug Discovery Market Size is Expected to Reach USD 120,809 million by 2030: Straits Research
05 déc. 2023 10h10 HE
|
Straits Research
New York, United States, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Drug discovery is the process of examining potential novel treatments, and it takes place in the domains of pharmacology, biotechnology,...
Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
28 nov. 2023 08h00 HE
|
Phathom Pharmaceuticals
VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available at major retail pharmacies and through BlinkRx.
Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
09 nov. 2023 08h00 HE
|
Phathom Pharmaceuticals
VOQUEZNA® (vonoprazan) tablets approved by the U.S. Food and Drug Administration (FDA) for the treatment of Erosive GERD and relief of associated heartburn in adults, marking the first major...
Data Acquisition System Market revenue to exceed USD 3.7 Billion by 2035, says Research Nester
07 nov. 2023 05h00 HE
|
Research Nester
New York, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global data acquisition (DAQ) system market size is projected to expand at ~5.5% CAGR between 2023 and 2035. The market is expected to garner a...